Bifurcation kinetics of drug uptake by Gram-negative bacteria

PLoS ONE

Volumn 12, Issue 9, 2017, Pages

  Westfall, David A ^a   Krishnamoorthy, Ganesh ^a   Wolloscheck, David ^a   Sarkar, Rupa ^a   Zgurskaya, Helen I ^a   Rybenkov, Valentin V ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; HOE 33342; ANTIINFECTIVE AGENT; BENZIMIDAZOLE DERIVATIVE; BISBENZIMIDE ETHOXIDE TRIHYDROCHLORIDE; DNA; OUTER MEMBRANE PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL OUTER MEMBRANE; CONTROLLED STUDY; DIFFUSION; DRUG ACCUMULATION; DRUG UPTAKE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IC50; MATHEMATICAL MODEL; MEASUREMENT ACCURACY; MEMBRANE PERMEABILITY; MICHAELIS MENTEN KINETICS; NONHUMAN; PREDICTION; STEADY STATE; TRANSPORT KINETICS; BIOLOGICAL MODEL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; KINETICS; METABOLISM;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BENZIMIDAZOLES; DNA; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; KINETICS; MODELS, BIOLOGICAL;

EID: 85029812724     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0184671     Document Type: Article

References (52)

1. Li XZ, Plesiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015; 28(2):337–418. https://doi.org/10.1128/CMR.00117-14 PMID: 25788514; PubMed Central PMCID: PMCPMC4402952.
2. Silver LL. Challenges of antibacterial discovery. Clin Microbiol Rev. 2011; 24(1):71–109. Epub 2011/01/ 15. https://doi.org/10.1128/CMR.00030-10 PMID: 21233508; PubMed Central PMCID: PMCPMC3021209.
3. Lewis K. Antibiotics: Recover the lost art of drug discovery. Nature. 2012; 485(7399):439–40. https://doi.org/10.1038/485439a PMID: 22622552.
4. Zgurskaya HI, Lopez CA, Gnanakaran S. Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It. Acs Infect Dis. 2015; 1(11):512–22. https://doi.org/10.1021/acsinfecdis.5b00097 PMID: 26925460; PubMed Central PMCID: PMCPMC4764994.
5. Trusts PC. A Scientific Roadmap for Antibiotic Discovery: a sustainable and robust pipeline of new antibacterial drugs and therapies is critical to preserve public health http://www.pewtrusts.org/en/projects/antibiotic-resistance-project: Pew Charitable Trusts; 2016 [cited 2016]. Available from: http://www.pewtrusts.org/en/projects/antibiotic-resistance-project.
6. Silver LL. A Gestalt approach to Gram-negative entry. Bioorg Med Chem. 2016; 24(24):6379–89. https://doi.org/10.1016/j.bmc.2016.06.044 PMID: 27381365.
7. Thanassi DG, Suh GS, Nikaido H. Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli. J Bacteriol. 1995; 177(4):998–1007. PMID: 7860612; PubMed Central PMCID: PMCPMC176695.
8. Ohki S, Spangler R. Passive and Facilitated Transport. The Structure of Biological Membranes, Second Edition: CRC Press; 2004.
9. Zhou Y, Joubran C, Miller-Vedam L, Isabella V, Nayar A, Tentarelli S, et al. Thinking outside the "bug": a unique assay to measure intracellular drug penetration in gram-negative bacteria. Anal Chem. 2015; 87(7):3579–84. https://doi.org/10.1021/ac504880r PMID: 25753586.
10. Eren E, Parkin J, Adelanwa A, Cheneke B, Movileanu L, Khalid S, et al. Toward understanding the outer membrane uptake of small molecules by Pseudomonas aeruginosa. J Biol Chem. 2013; 288 (17):12042–53. https://doi.org/10.1074/jbc.M113.463570 PMID: 23467408; PubMed Central PMCID: PMCPMC3636890.
11. Nagano K, Nikaido H. Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A. 2009; 106(14):5854–8. https://doi.org/10.1073/pnas.0901695106 PMID: 19307562; PubMed Central PMCID: PMCPMC2667059.
12. Lim SP, Nikaido H. Kinetic parameters of efflux of penicillins by the multidrug efflux transporter AcrAB-TolC of Escherichia coli. Antimicrob Agents Chemother. 2010; 54(5):1800–6. Epub 2010/02/18. https://doi.org/10.1128/AAC.01714-09 PMID: 20160052; PubMed Central PMCID: PMC2863684.
13. Ricci V, Piddock L. Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones. J Antimicrob Chemother. 2003; 52(4):605–9. https://doi.org/10.1093/jac/dkg418 PMID: 12951329.
14. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 2003; 67(4):593–656. Epub 2003/12/11. https://doi.org/10.1128/MMBR.67.4.593-656.2003 PMID: 14665678; PubMed Central PMCID: PMC309051.
15. Nikaido H, Rosenberg EY, Foulds J. Porin channels in Escherichia coli: studies with beta-lactams in intact cells. J Bacteriol. 1983; 153(1):232–40. Epub 1983/01/01. PMID: 6294048; PubMed Central PMCID: PMC217361.
16. Plesiat P, Nikaido H. Outer membranes of gram-negative bacteria are permeable to steroid probes. Mol Microbiol. 1992; 6(10):1323–33. https://doi.org/10.1111/j.1365-2958.1992.tb00853.x PMID: 1640833.
17. Pages JM, James CE, Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol. 2008; 6(12):893–903. Epub 2008/11/11. https://doi.org/10.1038/nrmicro1994 PMID: 18997824.
18. Schwarz G, Danelon C, Winterhalter M. On translocation through a membrane channel via an internal binding site: kinetics and voltage dependence. Biophys J. 2003; 84(5):2990–8. https://doi.org/10.1016/S0006-3495(03)70025-3 PMID: 12719230; PubMed Central PMCID: PMCPMC1302861.
19. Lomovskaya O, Zgurskaya HI, Bostian KA. Bacterial Multidrug Transporters: Molecular and Clinical Aspects. In: Ecker GF, Chiba P, editors. Transporters as Drug Carriers. Methods and Principles in Medicinal Chemistry. 33: Wiley and Sons; 2008. p. in press.
20. Zgurskaya HI, Weeks JW, Ntreh AT, Nickels LM, Wolloscheck D. Mechanism of coupling drug transport reactions located in two different membranes. Front Microbiol. 2015; 6:100. https://doi.org/10.3389/fmicb.2015.00100 PMID: 25759685; PubMed Central PMCID: PMCPMC4338810.
21. Ruggerone P, Murakami S, Pos KM, Vargiu AV. RND efflux pumps: structural information translated into function and inhibition mechanisms. Curr Top Med Chem. 2013; 13(24):3079–100. PMID: 24200360.
22. Du D, Wang Z, James NR, Voss JE, Klimont E, Ohene-Agyei T, et al. Structure of the AcrAB-TolC multidrug efflux pump. Nature. 2014; 509(7501):512–5. Epub 2014/04/22. https://doi.org/10.1038/nature13205 PMID: 24747401.
23. Daury L, Orange F, Taveau JC, Verchere A, Monlezun L, Gounou C, et al. Tripartite assembly of RND multidrug efflux pumps. Nat Commun. 2016; 7:10731. https://doi.org/10.1038/ncomms10731 PMID: 26867482; PubMed Central PMCID: PMCPMC4754349.
24. Lou H, Chen M, Black SS, Bushell SR, Ceccarelli M, Mach T, et al. Altered antibiotic transport in OmpC mutants isolated from a series of clinical strains of multi-drug resistant E. coli. PLoS One. 2011; 6(10): e25825. Epub 2011/11/05. https://doi.org/10.1371/journal.pone.0025825 PMID: 22053181; PubMed Central PMCID: PMC3203869.
25. Nakae T, Ishii JN, Tokunaga H, Kobayashi Y, Nakae R. The solute selectivity of porin pores of Escherichia coli and Salmonella typhimurium. Tokai J Exp Clin Med. 1982; 7 Suppl:141–8. Epub 1982/01/01. PMID: 6310821.
26. Rice LB. Mechanisms of Resistance and Clinical Relevance of Resistance to β-Lactams, Glycopeptides, and Fluoroquinolones. Mayo Clinic Proceedings. 2012; 87(2):198–208. http://dx.doi.org/10.1016/j.mayocp.2011.12.003. https://doi.org/10.1016/j.mayocp.2011.12.003 PMID: 22305032
27. Hajjar E, Bessonov A, Molitor A, Kumar A, Mahendran KR, Winterhalter M, et al. Toward screening for antibiotics with enhanced permeation properties through bacterial porins. Biochemistry. 2010; 49 (32):6928–35. https://doi.org/10.1021/bi100845x PMID: 20604536.
28. Pothula KR, Solano CJ, Kleinekathofer U. Simulations of outer membrane channels and their permeability. Biochim Biophys Acta. 2016; 1858(7 Pt B):1760–71. https://doi.org/10.1016/j.bbamem.2015.12.020 PMID: 26721326.
29. Nestorovich EM, Danelon C, Winterhalter M, Bezrukov SM. Designed to penetrate: Time-resolved interaction of single antibiotic molecules with bacterial pores. Proceedings of the National Academy of Sciences. 2002; 99(15):9789–94. https://doi.org/10.1073/pnas.152206799 PMID: 12119404
30. Kojima S, Nikaido H. Permeation rates of penicillins indicate that Escherichia coli porins function principally as nonspecific channels. Proc Natl Acad Sci U S A. 2013; 110(28):E2629–34. https://doi.org/10.1073/pnas.1310333110 PMID: 23798411; PubMed Central PMCID: PMCPMC3710850.
31. Lewinson O, Adler J, Poelarends GJ, Mazurkiewicz P, Driessen AJ, Bibi E. The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions. Proc Natl Acad Sci U S A. 2003; 100(4):1667–72. https://doi.org/10.1073/pnas.0435544100 PMID: 12578981.
32. Bolhuis H, van Veen HW, Brands JR, Putman M, Poolman B, Driessen AJ, et al. Energetics and mechanism of drug transport mediated by the lactococcal multidrug transporter LmrP. J Biol Chem. 1996; 271(39):24123–8. PMID: 8798651.
33. Tikhonova EB, Devroy VK, Lau SY, Zgurskaya HI. Reconstitution of the Escherichia coli macrolide transporter: the periplasmic membrane fusion protein MacA stimulates the ATPase activity of MacB. Mol Microbiol. 2007; 63(3):895–910. https://doi.org/10.1111/j.1365-2958.2006.05549.x PMID: 17214741.
34. Nikaido H, Pages JM. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev. 2012; 36(2):340–63. Epub 2011/06/29. https://doi.org/10.1111/j.1574-6976.2011.00290.x PMID: 21707670; PubMed Central PMCID: PMCPMC3546547.
35. Lu P, Liu R, Sharom FJ. Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state. Eur J Biochem. 2001; 268 (6):1687–97. PMID: 11248688.
36. Bezrukov SM, Berezhkovskii AM, Szabo A. Diffusion model of solute dynamics in a membrane channel: mapping onto the two-site model and optimizing the flux. J Chem Phys. 2007; 127(11):115101. https://doi.org/10.1063/1.2766720 PMID: 17887882.
37. Bauer WR, Nadler W. Molecular transport through channels and pores: effects of in-channel interactions and blocking. Proc Natl Acad Sci U S A. 2006; 103(31):11446–51. https://doi.org/10.1073/pnas.0601769103 PMID: 16861303; PubMed Central PMCID: PMCPMC1513537.
38. Chen AY, Yu C, Bodley A, Peng LF, Liu LF. A new mammalian DNA topoisomerase I poison Hoechst 33342: cytotoxicity and drug resistance in human cell cultures. Cancer Res. 1993; 53(6):1332–7. PMID: 8383008.
39. Shapiro AB, Ling V. Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein. Eur J Biochem. 1997; 250(1):122–9. PMID: 9431999.
40. Margolles A, Putman M, van Veen HW, Konings WN. The purified and functionally reconstituted multidrug transporter LmrA of Lactococcus lactis mediates the transbilayer movement of specific fluorescent phospholipids. Biochemistry. 1999; 38(49):16298–306. PMID: 10587454.
41. Putman M, Koole LA, van Veen HW, Konings WN. The secondary multidrug transporter LmrP contains multiple drug interaction sites. Biochemistry. 1999; 38(42):13900–5. PMID: 10529235.
42. Coldham NG, Webber M, Woodward MJ, Piddock LJ. A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli. J Antimicrob Chemother. 2010; 65(8):1655–63. https://doi.org/10.1093/jac/dkq169 PMID: 20513705.
43. Richmond GE, Chua KL, Piddock LJ. Efflux in Acinetobacter baumannii can be determined by measuring accumulation of H33342 (bis-benzamide). J Antimicrob Chemother. 2013; 68(7):1594–600. https://doi.org/10.1093/jac/dkt052 PMID: 23467176; PubMed Central PMCID: PMCPMC3682688.
44. Muller H, Klinkhammer W, Globisch C, Kassack MU, Pajeva IK, Wiese M. New functional assay of P-glycoprotein activity using Hoechst 33342. Bioorg Med Chem. 2007; 15(23):7470–9. https://doi.org/10.1016/j.bmc.2007.07.024 PMID: 17890094.
45. Mohammad MM, Howard KR, Movileanu L. Redesign of a plugged beta-barrel membrane protein. J Biol Chem. 2011; 286(10):8000–13. https://doi.org/10.1074/jbc.M110.197723 PMID: 21189254; PubMed Central PMCID: PMC3048687.
46. Krishnamoorthy G, Wolloscheck D, Weeks JW, Croft C, Rybenkov VV, Zgurskaya HI. Breaking the Permeability Barrier of Escherichia coli by Controlled Hyperporination of the Outer Membrane. Antimicrob Agents Chemother. 2016; 60(12):7372–81. https://doi.org/10.1128/AAC.01882-16 PMID: 27697764; PubMed Central PMCID: PMCPMC5119019.
47. Asuquo AE, Piddock LJ. Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother. 1993; 31(6):865–80. PMID: 8360125.
48. Gutfreund H. Kinetic analysis of the properties and reactions of enzymes. Prog Biophys Mol Biol. 1975; 29(2):161–95. PMID: 1135418.
49. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000; 97(12):6640–5. https://doi.org/10.1073/pnas.120163297 PMID: 10829079.
50. Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature. 2000; 405(6789):914–9. https://doi.org/10.1038/35016007 PMID: 10879525.
51. Neidhardt FC, Umbarger HE. Chemical Composition of Escherichia coli. In: Neidhardt FC, editor. Escherichia coli and Salmonella: Cellular and Molecular Biology. 1: American Society of Microbiology (ASM) Press; 1996.
52. Petrushenko ZM, She W, Rybenkov VV. A new family of bacterial condensins. Mol Microbiol. 2011; 81 (4):881–96. Epub 2011/07/15. https://doi.org/10.1111/j.1365-2958.2011.07763.x PMID: 21752107.